Current availability: Demonstration. Monitoring requires qualified sources. Similarity is not an infringement finding; claims and rights require qualified review.
A small change. A consequential next question.
Product preview — not live
Know exactly what was seen.
Source specimen · not monitored evidence
See the difference, side by side.
Reference A Silver cap · pale jar→
Reference B Gold cap · green jar
Evidence before interpretation.
What changed?
Packaging
Colour and cap finish differ
Claim
No claim conclusion inferred
Formula
Cannot be inferred from a label
Route the finding to the right person.
Who should review?
Brand owner
Review differentiation
Product expert
Assess disclosed claims
Counsel
Review rights where relevant
Select a stage to inspect the example. No external action, product claim or business outcome is confirmed here.
HALO SIGNALPRODUCT VISION · DEMONSTRATION
PricingDemandMarket contextCompetitionPositioning
Observed changeExample competitor revises a product bundleSource needed
Commercial meaningCompare like-for-like value, not price aloneHypothesis
Recommended reviewValidate the offer and capture dated evidenceHuman review
Protect / Designed outputs
HALO Signal / Watch™
↗Source-linked commercial signals
↗Brand and product comparisons
↗Prioritised findings for qualified review
Connect observed changes to affected brands, products and markets. Preserve the evidence, uncertainty and recommended reviewer instead of turning similarity into an accusation.
External execution is not yet qualified. Public ingredient lists do not establish a complete formulation. Similarity does not establish copying, infringement, efficacy or safety.
Authorised public or licensed sources
Defined monitored assets and refresh policy
Qualified review and escalation ownership
Product access does not grant permission to execute. Identity, tenant, provider readiness and action scope are verified separately.